Ahn-Gook Pharmaceutical Co. Ltd (001540) — Cash Flow Reinvestment Rate
Ahn-Gook Pharmaceutical Co. Ltd (001540) has a Cash Flow Reinvestment Rate of 0.22x as of September 2025, reinvesting ₩3.11 Billion (capex ₩2.76 Billion plus investments ₩-351.36 Million) from operating cash flow of ₩14.44 Billion. See Ahn-Gook Pharmaceutical Co. Ltd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Ahn-Gook Pharmaceutical Co. Ltd Cash Flow Reinvestment Rate (2012–2024)
Historical reinvestment intensity for Ahn-Gook Pharmaceutical Co. Ltd across 11 annual periods. For the full cash flow conversion analysis, see Ahn-Gook Pharmaceutical Co. Ltd (001540) cash conversion ratio.
Annual Cash Flow Reinvestment Rate for Ahn-Gook Pharmaceutical Co. Ltd (2012–2024)
Year-by-year capital reinvestment analysis for Ahn-Gook Pharmaceutical Co. Ltd. See Ahn-Gook Pharmaceutical Co. Ltd (001540) flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 30.78x | ₩151.27 Billion | ₩4.91 Billion | ₩75.89 Billion | ▲ +327.1% |
| 2022 | 7.21x | ₩12.89 Billion | ₩1.79 Billion | ₩2.93 Billion | ▲ +18.4% |
| 2021 | 6.09x | ₩8.97 Billion | ₩1.47 Billion | ₩4.04 Billion | ▲ +74.1% |
| 2020 | 3.50x | ₩39.14 Billion | ₩11.19 Billion | ₩24.12 Billion | ▲ +191.1% |
| 2019 | 1.20x | ₩26.53 Billion | ₩22.08 Billion | ₩3.74 Billion | ▲ +146.3% |
| 2017 | 0.49x | ₩8.52 Billion | ₩17.46 Billion | ₩4.79 Billion | ▼ -21.9% |
| 2016 | 0.62x | ₩7.89 Billion | ₩12.62 Billion | ₩4.38 Billion | ▼ -26.7% |
| 2015 | 0.85x | ₩16.28 Billion | ₩19.11 Billion | ₩2.33 Billion | ▼ -92.2% |
| 2014 | 10.99x | ₩14.14 Billion | ₩1.29 Billion | ₩7.16 Billion | ▲ +507.0% |
| 2013 | 1.81x | ₩6.60 Billion | ₩3.64 Billion | ₩6.60 Billion | ▲ +708.3% |
| 2012 | 0.22x | ₩2.58 Billion | ₩11.51 Billion | ₩2.58 Billion | — |